行情

PRGO

PRGO

培瑞克
NYSE

实时行情|Nasdaq Last Sale

43.00
+0.23
+0.54%
盘后: 42.74 -0.26 -0.60% 17:36 09/24 EDT
开盘
42.58
昨收
42.77
最高
43.14
最低
42.57
成交量
89.98万
成交额
--
52周最高
49.91
52周最低
38.20
市值
57.50亿
市盈率(TTM)
-13.2679
分时
5日
1月
3月
1年
5年
标准普尔 500 指数纳入后匹配组下跌
Match Group (MTCH -2.1%) trades down following its inclusion in the S&P 500 today. The stock surged 11% on Sept 3 following the announcement that it, software company Ceridian HCM Holding
Seekingalpha · 5天前
为什么 Perrigo (PRGO) 自上次收益报告以来上涨了 7.1%?
Zacks.com · 09/10 15:30
Perrigo (PRGO) 收购另一家自理公司 HRA Pharma
Perrigo (PRGO) offers to acquire HRA Pharma with several leading OTC brands in its portfolio for almost $2.1 billion. The acquisition will complete Perrigo's transformation into a leading self-care company.
Zacks · 09/09 14:10
华尔街收低,受大型科技公司拖累
Wall Street ended lower on Wednesday, spooked by worries that the Delta coronavirus variant could blunt the economy's recovery and on uncertainty about when the Federal Reserve may pull back its accommodative policies.
Reuters · 09/08 23:37
为什么 Perrigo 的股票今天交易更高
Perrigo Company plc (NYSE: PRGO) shares are trading higher after the company announced it will acquire HRA Pharma for $2.1 billion in cash. "The acquisition of HRA would be the crowning achievement in that transformation. With the addition of HRA and its t...
Benzinga · 09/08 19:56
Perrigo 同意以 21 亿美元现金收购 Hera
Perrigo is buying Hera from funds affiliated with private equity firm Astorg and Goldman Sachs Asset Management.
TheStreet.com · 09/08 17:20
Perrigo 以 21 亿美元收购 HRA Pharma 以扩大自我护理产品组合
Perrigo Company Plc said on Wednesday it would buy HRA Pharma from investment firms Astorg and Goldman Sachs Asset Management in a deal valued at 1.8 billion euros ($2.13 billion) to bolster its over-the-counter self-care offerings, sending its shares up 6...
Reuters · 09/08 14:53
Perrigo 以 21 亿美元的价格收购消费者自我保健公司 HRA Pharma。股价上涨。
Perrigo has agreed to buy consumer self-care company HRA Pharma in a deal worth around $2.1 billion in cash, sending the stock higher in early trading.
Barrons.com · 09/08 13:44
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解PRGO最新的财务预测,通过PRGO每股收益,每股净资产,每股现金流等数据分析培瑞克近期的经营情况,然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测PRGO价格均价为51.00,最高价位60.00,最低价为45.00。
EPS
机构持股
总机构数: 471
机构持股: 1.39亿
持股比例: 103.59%
总股本: 1.34亿
类型机构数股数
增持
107
678.32万
建仓
44
318.52万
减持
99
515.59万
平仓
59
212.74万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.45%
制药与医学研究
-1.02%
高管信息
Non-Executive Chairman/Independent Director
Rolf Classon
President/Chief Executive Officer/Director
Murray Kessler
Chief Financial Officer/Executive Vice President
Raymond Silcock
Chief Human Resource Officer/Executive Vice President
Robert Willis
Executive Vice President/Chief Information Officer
Thomas Farrington
Executive Vice President/Chief Scientific Officer
James Dillard
Executive Vice President/General Counsel/Secretary
Todd Kingma
Executive Vice President/General Manager
Richard Sorota
Executive Vice President
Svend Andersen
Executive Vice President
Ronald Janish
Executive Vice President
Sharon Kochan
Executive Vice President
Grainne Quinn
Independent Director
Bradley Alford
Independent Director
Orlando Ashford
Independent Director
Katherine Doyle
Independent Director
Adriana Karaboutis
Independent Director
Jeffrey Kindler
Independent Director
Erica Mann
Independent Director
Donal O'Connor
Independent Director
Geoffrey Parker
Independent Director
Theodore Samuels
公告日期
每股分红
除权日期
2021/08/03
每股分红:USD 0.24
2021/09/02
--
每股分红:USD 0.24
2021/06/03
2021/02/23
每股分红:USD 0.24
2021/03/11
2020/10/22
每股分红:USD 0.225
2020/11/25
2020/07/29
每股分红:USD 0.225
2020/08/27
2020/05/05
每股分红:USD 0.225
2020/05/28
2020/02/18
每股分红:USD 0.225
2020/02/27
2019/11/04
每股分红:USD 0.21
2019/11/27
2019/07/31
每股分红:USD 0.21
2019/08/29
2019/04/26
每股分红:USD 0.21
2019/05/30
2019/02/14
每股分红:USD 0.19
2019/02/28
2018/10/31
每股分红:USD 0.19
2018/11/29
2018/08/01
每股分红:USD 0.19
2018/08/30
2018/05/03
每股分红:USD 0.19
2018/05/31
2018/02/15
每股分红:USD 0.19
2018/03/01
2017/11/02
每股分红:USD 0.16
2017/11/30
2017/08/08
每股分红:USD 0.16
2017/08/23
2017/05/03
每股分红:USD 0.16
2017/05/24
2017/02/21
每股分红:USD 0.16
2017/03/01
2016/11/08
每股分红:USD 0.145
2016/11/22
PRGO 简况
Perrigo Co Plc是非处方 (OTC) 健康和保健解决方案的提供商。其解决方案使消费者能够预防或治疗可以自我管理的疾病。该公司通过两个分部运营:美洲消费者自我保健分部和国际消费者自我保健分部。美洲消费者自我保健分部包括美国(U.S.)、墨西哥和加拿大的消费者自我保健业务(非处方药、婴儿配方奶粉和口腔自我保健类别以及合同制定)。美洲消费者自我保健分部产品以Prevacid 24HR、Good Sense、Zephrex D、ScarAway、Plackers、Rembrandt、Steripod和Firefly等品牌销售。国际消费者自我保健分部包括主要欧洲和澳大利亚的品牌消费者自我保健业务、英国以及欧洲和亚洲部分地区的商店品牌业务。国际消费者自我保健分部主要专注于建立通过经销商、药店、药房和电子商务渠道销售的本地和区域品牌。

微牛提供Perrigo Company PLC(NYSE-PRGO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的PRGO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易PRGO股票基本功能。